Bedside Rounds

Hypertensive emergency: workup and management

Severe hypertension (usually >180/120 mmHg) with acute target-organ damage is a hypertensive emergency needing IV therapy and controlled lowering in a monitored setting. Severe hypertension without organ damage is managed with oral agents and outpatient follow-up; rapid lowering is harmful.

Working diagnosis Adult · US guidelines Draft · awaiting physician review
Tailor to a patient with AI Bedside calculators Report an error

01Orient

What's new in the evidence

  • 2025 AHA/ACC multisociety BP guideline: hypertensive emergency (>180/120 mmHg with acute target-organ damage) is managed in the ICU
  • Compelling conditions (aortic dissection, severe preeclampsia/eclampsia, pheochromocytoma crisis): SBP <140 mmHg within the first hour, <120 mmHg in aortic dissection
  • Without a compelling condition: lower by ≤25% in the first hour, to <160/100 over 2–6 hours, then to 130–140 systolic over 24–48 hours
  • New Class 3 (Harm): do not give PRN IV or oral antihypertensives for asymptomatic severe hypertension in patients admitted for other conditions
  • 2024 AHA scientific statement: treat causes of inpatient BP spikes (pain, withdrawal, missed home medications) and restart the home regimen

Differential diagnoses

  1. Hypertensive emergency with encephalopathy, stroke, ACS, acute heart failure, AKI or retinopathy
  2. Aortic dissection (can't miss)
  3. Preeclampsia or eclampsia (can't miss)
  4. Stimulant use (cocaine, amphetamines), withdrawal from clonidine or beta-blockers
  5. Severe hypertension without organ damage ("urgency") due to nonadherence, pain or anxiety
  6. Pheochromocytoma, renovascular disease

02Assess

Risk scores and decision tools

  • Target-organ damage checklist: brain, heart, aorta, kidney, retina, placenta
  • Aortic Dissection Detection Risk Score if chest or back pain
  • Fundoscopy grading for retinopathy

Key history questions

  • Headache, confusion, visual change, seizures
  • Chest or back pain, dyspnea
  • Antihypertensive adherence; recent stopping of clonidine or beta-blockers
  • Stimulants, MAOIs, decongestants, NSAIDs
  • Pregnancy or recent delivery

Examination findings

  • BP in both arms with the right cuff size; repeat after rest
  • Fundoscopy: hemorrhages, exudates, papilledema
  • Neurological exam
  • Heart failure signs, pulse deficits (dissection)

03Investigate

Initial investigations

  • BMP, creatinine, urinalysis (protein, blood)
  • ECG, troponin
  • CBC with smear (thrombotic microangiopathy), LDH
  • Pregnancy test

Advanced investigations

  • CT head if neurological signs
  • CT angiography if dissection suspected
  • Chest X-ray, echocardiogram as indicated

04Treat

Immediate management

  • Hypertensive emergency: ICU or step-down, arterial line when possible
  • No compelling condition: lower BP by no more than 25% in the first hour, then to <160/100 over 2–6 hours, then toward 130–140 systolic over 24–48 hours
  • Nicardipine infusion 5 mg/h, titrated by 2.5 mg/h every 5–15 min (max 15 mg/h), or clevidipine; nicardipine reaches target more often than labetalol
  • Labetalol IV boluses or infusion if no contraindication

First-line treatment

  • Aortic dissection: HR <60 and SBP <120 within 20 minutes (esmolol first, then a vasodilator)
  • Severe preeclampsia/eclampsia: IV labetalol or hydralazine, or oral nifedipine, plus magnesium; SBP <140 within the first hour
  • Acute ischemic stroke: follow stroke-specific BP targets
  • Asymptomatic severe inpatient hypertension: no PRN IV antihypertensives; treat pain or withdrawal, resume home medications, titrate oral agents

Second-line treatment

  • Sympathomimetic (cocaine): benzodiazepines first; avoid beta-blockers alone
  • Pulmonary edema: nitroglycerin plus diuretic if volume overloaded

Specialist referrals

  • ICU for hypertensive emergency
  • Cardiothoracic surgery for type A dissection
  • Obstetrics for preeclampsia

05Disposition

Admission criteria

  • Any acute target-organ damage

Safe discharge criteria

  • No target-organ damage on evaluation
  • Oral regimen restarted or started; follow-up within 1 week

Follow-up timing

  • Primary care within 1 week

Patient instructions

  • Take medications daily; home BP monitoring
  • Return for headache, chest pain, weakness or vision change

Monitoring

  • BP every 5–15 minutes while titrating IV therapy
  • Renal function and neuro checks

Clinical pearls and pitfalls

  • Rapid normalization can cause stroke, MI or AKI because autoregulation has shifted
  • Avoid sublingual nifedipine and IV hydralazine as first choices outside pregnancy (unpredictable drops)
  • Search for secondary causes in young patients or resistant hypertension

RefGuidelines and landmark evidence

For education only. Typical adult starting points; confirm doses against renal function, allergies, interactions and your institution's protocols. Not a substitute for clinical judgment or senior review.